Tired of ads? Enjoy an ad-free experience by signing up.
👩‍🍳 How we use AI at Tech in Asia, thoughtfully and responsibly.
🧔‍♂️ A friendly human may check it before it goes live. More news here

India’s Livlong 365 to invest $11.4m for 100 new branches

Livlong 365, a healthtech platform backed by IIFL Group, plans to invest about 100 crore rupees (US$11.4 million) from internal funds to expand its physical branches across India.

The company, founded in 2021, operates in preventive care, insurance distribution, diagnostics, and telehealth, with a focus on outpatient services.

Livlong 365 aims to open 100 branches by 2027 and increase outpatient care and insurance access in tier-I and tier-II cities.

The company said it is targeting US$400 million to US$500 million in revenue over the next five years.

Livlong 365 offers services including doctor consultations, diagnostic tests, health plans, OPD packages, home care, and online medicine sales.

🔗 Source: The Economic Times


🧠 Food for thought

1️⃣ Physical expansion addresses critical healthcare access gaps in tier cities

Livlong’s plan to open 100 physical branches by 2027 directly targets a significant healthcare infrastructure problem in India’s smaller cities.

Tier II and III cities currently face severe doctor shortages, with doctor-to-patient ratios as low as 1:25,000, which is well below WHO standards1.

This creates a substantial opportunity for companies that can establish reliable healthcare infrastructure in these underserved markets.

The company’s focus on outpatient departments makes strategic sense given that patients in these cities often must travel to metropolitan areas for basic healthcare services, creating both inconvenience and additional costs1.

By positioning physical branches in tier-I and tier-II cities, Livlong is building the healthcare infrastructure that government initiatives like Ayushman Bharat aim to support but haven’t fully addressed through private sector participation.

2️⃣ Self-funded expansion reflects confidence in preventive healthcare market growth

Livlong’s decision to use Rs 100 crore from internal accruals rather than external funding suggests strong cash generation and confidence in market timing.

This approach positions them well in India’s preventive healthcare sector, which is projected to grow at 22% CAGR and reach $197 billion by 2025, outpacing the broader healthcare market’s 15% growth rate2.

Stay ahead in Asia’s tech landscape

You've reached your 2 free content limit for the month. Sign up for free to read the full story.

🏄 For casual readers / 👶 Free

Basic

US$0

Free forever

Get instant access to this article and more every month

0 premium content

Unlimited news briefs

5

5 articles

Ad-free reading experience

Just US$0 per day

⌛Sign up in 20s. No payment details needed.

📖 For learners / 👍 Starter

Lite

US$4.92/month

Billed annually at US$59/year

Get instant access to this article and more every month

4

4 premium content

Unlimited news briefs & articles

Ad-free reading experience

Just US$0.17 per day

Cancel anytime

Our subscriber community includes professionals from these companies:

Stay updated on the go with our mobile app.

Get latest insights with smoother, more personalized experience through TIA mobile app.